NCT02794701

Brief Summary

Objectives: This study aims to explore the risk profiles among people with silicosis in Hong Kong underpinned by the Pittsburgh Mind-Body Center model. Design and subjects: This study will adopt a cross-sectional study design with sampling stratified by participants' degree of incapability. 320 Chinese people diagnosed with silicosis and registered with the Pneumoconiosis Compensation Fund Board will be recruited. Data collection: A demographic data sheet and the St. George's Respiratory Questionnaire will be used to collect the socio-demographic and clinical characteristics of the participants. The behavioral factors (smoking, drinking, physical activity level, consumption of vegetable and fruits and plasma vitamin C level) as well as the psychological risk factors (anxiety and depressive symptoms, and social support) will be examined by validated questionnaires. Biological and physiological parameters, including insulin resistance, C-reactive protein, hemoglobin, fasting blood glucose and lipid profiles, will be ascertained by fasting blood sample. Data analysis and expected outcomes: The findings of this study will create the database profile of the physical, psychosocial and disease specific aspects among people with silicosis in Hong Kong, subsequently forming the empirical basis of an intervention to tackle the identified modifiable risks among them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
390

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 9, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

July 6, 2018

Status Verified

July 1, 2018

Enrollment Period

10 months

First QC Date

May 30, 2016

Last Update Submit

July 5, 2018

Conditions

Outcome Measures

Primary Outcomes (14)

  • Respiratory symptoms and related physical limitation

    examined by Hong Kong Chinese version of St. George's Respiratory Questionnaire

    baseline

  • Psychological status

    Anxiety and depression symptoms measured by the Chinese version of Hospital Anxiety and Depression Scale

    baseline

  • Quality of life

    examined by the SF-12v2

    baseline

  • Social support

    measured by the Chinese version of six-item Social Support Questionnaire

    baseline

  • Body mass index

    BMI in kg/m\^2

    baseline

  • waist circumference

    WC in cm

    baseline

  • 12-hour fasting lipid profile

    total-cholesterol, HDL-Cholesterol, LDL-cholesterol and triglycerides (in mmol/L)

    baseline

  • 12-hour fasting glucose

    FG in mmol/L

    baseline

  • fasting insulin level

    insulin in pmol/L

    baseline

  • 12 hour fasting ascorbic acid level

    vit-C in mg/dL

    baseline

  • fasting high sensitivity C-reactive protein level

    hs-CRP in mg/L

    baseline

  • hemoglobin level

    hemoglobin in g/dL

    baseline

  • smoking and drinking habits, vegetable and fruit intake

    questions adopted from the Behavioral Risk Factor Surveillance of the Department of Health, Hong Kong SAR

    baseline

  • Physical activity level

    measured by the International Physical Activity Questionnaire - Short Form

    baseline

Study Arms (1)

people with silicosis

Other: People with silicosis

Interventions

people with silicosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A convenience sample of 390 eligible participants registered with the Pneumoconiosis Compensation Fund Board will be recruited with stratification by their degree of incapacity \[(i) \<30%, (ii) 30% - 60%, and (iii) \>60%\], in which the minimal number of participants in each strata will be 30.

You may qualify if:

  • Hong Kong Chinese-speaking residents and Chinese ethnicity;
  • diagnosis of silicosis and confirmed by the Pneumoconiosis Medical Board
  • registered with the Pneumoconiosis Compensation Fund Board (PCFB); and
  • able and willing to give informed written consent

You may not qualify if:

  • With medically diagnosed mental illness, including major depression, or
  • with active pulmonary tuberculosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Nethersole School of Nursing, Chinese University of Hong Kong

Hong Kong SAR, China

Location

MeSH Terms

Conditions

Silicosis

Condition Hierarchy (Ancestors)

PneumoconiosisLung Diseases, InterstitialLung DiseasesRespiratory Tract DiseasesLung InjuryOccupational Diseases

Study Officials

  • Ho Yu CHENG, PhD, RN

    The Nethersole School of Nursing, Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
post-doctoral fellow

Study Record Dates

First Submitted

May 30, 2016

First Posted

June 9, 2016

Study Start

June 1, 2016

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

July 6, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations